Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment

被引：31

作者：

Cai, Qingqing ^{[1
]}

Fang, Yu ^{[1
]}

Young, Ken H. ^{[2
]}

机构：

[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd, Houston, TX 77030 USA

来源：

TRANSLATIONAL ONCOLOGY | 2019年 / 12卷 / 03期

基金：

中国国家自然科学基金;

关键词：

PRIMARY CNS LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; WHOLE-BRAIN RADIOTHERAPY; STEM-CELL TRANSPLANTATION; INTERNATIONAL EXTRANODAL LYMPHOMA; RECURRENT PRIMARY CNS; UNDER-THE-CURVE; SALVAGE THERAPY; INTENSIVE CHEMOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.1016/j.tranon.2018.11.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Primary central nervous system lymphoma (PCNSL) is a group of extranodal non-Hodgkin lymphoma that exhibits specific biological characteristics and clinical behavior, with an aggressive disease course and unsatisfactory patient outcomes. It is of great importance to identify aberrant genetic loci and important molecular pathways that might suggest potential targets for new therapeutics and provide prognostic information. In this review, we listed various genetic and epigenetic alterations that are involved in PCNSL pathogenesis. In the aspect of treatment, we summarized the related literatures and evaluated the efficacy of surgery, induction chemotherapy, radiotherapy, intrathecal chemotherapy, and autologous stem cell transplantation in PCNSL. We also proposed the possible new agents for recurrent and relapse PCNSL based on the result of recent clinical researches.

引用

页码：523 / 538

页数：16

共 139 条

[101] Primary central nervous system lymphoma: essential points in diagnosis and management [J].

Paydas, Semra .

MEDICAL ONCOLOGY, 2017, 34 (04)

[102] Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy [J].

Pels, H ;

Schmidt-Wolf, IGH ;

Glasmacher, A ;

Schulz, H ;

Engert, A ;

Diehl, V ;

Zellner, A ;

Schackert, G ;

Reichmann, H ;

Kroschinsky, F ;

Vogt-Schaden, M ;

Egerer, G ;

Bode, U ;

Schaller, C ;

Deckert, M ;

Fimmers, R ;

Helmstaedter, C ;

Atasoy, A ;

Klockgether, T ;

Schlegel, U .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4489-4495

[103] Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma [J].

Pels, Hendrik ;

Juergens, Annika ;

Schirgens, Isabell ;

Glasmacher, Axel ;

Schulz, Holger ;

Engert, Andreas ;

Schackert, Gabriele ;

Reichmann, Heinz ;

Kroschinsky, Frank ;

Vogt-Schaden, Marlies ;

Egerer, Gerlinde ;

Bode, Udo ;

Deckert, Martina ;

Fimmers, Rolf ;

Urbach, Horst ;

Schmidt-Wolf, Ingo G. H. ;

Schlegel, Uwe .

NEURO-ONCOLOGY, 2010, 12 (07) :720-724

[104] Methotrexate re-challenge for recurrent primary central nervous system lymphoma [J].

Pentsova, Elena ;

DeAngelis, Lisa M. ;

Omuro, Antonio .

JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (01) :161-165

[105] 2-photon imaging of phagocyte-mediated T cell activation in the CNS [J].

Pesic, Marija ;

Bartholomaeus, Ingo ;

Kyratsous, Nikolaos I. ;

Heissmeyer, Vigo ;

Wekerle, Hartmut ;

Kawakami, Naoto .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03) :1192-1201

[106] Treatment of relapsed central nervous system lymphoma with high-dose methotrexate [J].

Plotkin, SR ;

Betensky, RA ;

Hochberg, FH ;

Grossman, SA ;

Lesser, GJ ;

Nabors, LB ;

Chon, B ;

Batchelor, TT .

CLINICAL CANCER RESEARCH, 2004, 10 (17) :5643-5646

[107] Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas [J].

Ponzoni, M. ;

Berger, F. ;

Chassagne-Clement, C. ;

Tinguely, M. ;

Jouvet, A. ;

Ferreri, A. J. M. ;

Dell'Oro, S. ;

Terreni, M. R. ;

Doglioni, C. ;

Weis, J. ;

Cerati, M. ;

Milani, M. ;

Iuzzolino, P. ;

Motta, T. ;

Carbone, A. ;

Pedrinis, E. ;

Sanchez, J. ;

Blay, J.-Y. ;

Reni, M. ;

Conconi, A. ;

Bertoni, F. ;

Zucca, E. ;

Cavalli, F. ;

Borisch, B. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (03) :316-323

[108] Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis [J].

Prica, Anca ;

Chan, Kelvin ;

Cheung, Matthew C. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) :600-607

[109] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma [J].

Raizer, Jeffrey J. ;

Rademaker, Alfred ;

Evens, Andrew M. ;

Rice, Laurie ;

Schwartz, Margaret ;

Chandler, James P. ;

Getch, Christopher C. ;

Tellez, Claudia ;

Grimm, Sean A. .

CANCER, 2012, 118 (15) :3743-3748

[110] Temozolomide as salvage treatment in primary brain lymphomas [J].

Reni, M. ;

Zaja, F. ;

Mason, W. ;

Perry, J. ;

Mazza, E. ;

Spina, M. ;

Bordonaro, R. ;

Ilariucci, F. ;

Faedi, M. ;

Corazzelli, G. ;

Manno, P. ;

Franceschi, E. ;

Pace, A. ;

Candela, M. ;

Abbadessa, A. ;

Stelitano, C. ;

Latte, G. ;

Ferreri, A. J. M. .

BRITISH JOURNAL OF CANCER, 2007, 96 (06) :864-867

← 5 6 7 8 9 10 11 12 13 14 →